Genevant Sciences
Gregg Ashby is an experienced finance executive currently serving as Vice President of Finance at Genevant Sciences since December 2020, following a role as Senior Director of Finance at the same company. Prior to this, Gregg held the position of Director of Finance and Operations at Renewal Funds, a mission-driven venture capital fund focused on sustainability. Previous experience includes a Senior Director of Finance role at Arbutus Biopharma Corporation, where the focus was on developing therapies for chronic hepatitis B. Gregg has also served as Director of Finance at Motivus Software Ltd., Group Controller at GPS Industries, and held various audit positions at EY and Kidsons. Educational qualifications include CPA certification from the Institute of Chartered Accountants in British Columbia, Chartered Accountant designation from ICAEW, and a Bachelor of Science (Honours) in Business Studies from Aston University.
This person is not in any teams
This person is not in any offices
Genevant Sciences
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. They leverage world-class delivery systems and related technologies to bring new medicines to patients who need them. Genevant does this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows them to maintain our leadership position in the space.